RYCA INTERNATIONAL
OperatingRyca International, Inc.
Healthcare · Los Angeles, CA · Founded 2007
Effortless Oral Care
Financials
FY2018–FY2023 (no data for FY2021) · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round. Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth, so don't compare them with the other bars.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of Nov 25, 2020| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 5,590,631 | 1 | 100.0% | — |
Principal holders% as the filing states it, Dec 21, 2021
- Ryan Schwartz2,089,131 Common Stock32.0%of
- Cary Schwartz1,436,275 Common Stock22.0%of
Sold to the crowd
- Reg CF · Apr 2020Non-Voting Common Stock$1.1M· 1,965 investors
- Reg CF · Sep 2024135,456 shares at $3.50$474.1K· 95 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
7 people
Experienced entrepreneur and leader proficient in raising capital, procuring talent and building strong brands in multiple successful startups within mortgage, marketing and film industries. Ryan works full time as Ryca's CEO. Ryan also teaches film on a very limited basis at New York Film Academy and maintains ongoing film projects through his production company Trustfall Films. Education MFA, Film Production, University of Southern California Bachelor's Degree, International Relations and Affairs, University of California, Berkeley
Former Director of Engineering for Sonicare and Clarisonic. Responsible for engineering/R&D, worldwide sourcing, tooling development, quality and regulatory compliance. Inventor on 25+ U.S. Patents and more worldwide. Gerald works full time with the Company.
25+ years of executive leadership experience in finance and operations with oversight of strategic planning, compliance, human resources, IT, investor relations and all financial functions. He has developed an identity as a creative problem solver and the “go to” person to think through complex situations and develop strategic and tactical plans to bring about the desired results. His financial management experience includes mergers & acquisition, strategic planning, financial planning (short and long term), SEC reporting, investor relations, financial audit, budgeting, revenue management, financial controls and financial reporting. Scott works approximately 20 hours per week for the Company. Scott also provides miscellaneous financial support to Casa de Amparo and Motivating the Masses, Inc. Education Master of Business Administration, University of California, Irvine Bachelor's Degree in Economics, University of Redlands
Executive with 20+ yrs helping medical device and pharmaceutical companies optimize their people and business strategies, ensure regulatory and quality compliance, and implement best practices to accelerate time to market. Summer works full time with the Company. Education Doctor of Philosophy (Ph.D.), Industrial Organizational Psychology, CSPP Bachelor's Degree in Psychology, Scripps College
Names and titles as disclosed on SEC Form 1-A, SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 6 annual reports (FY2020–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGAR- Form C-UFeb 11, 20250001665160-25-000230EDGAR
- Form C/ANov 25, 20240001665160-24-001702EDGAR
- Form C/ASep 20, 20240001665160-24-001328EDGAR
- Form CSep 5, 20240001665160-24-001279EDGAR
- Form C-TRApr 30, 20240001810373-24-000001EDGAR
- Form C-AR/ADec 21, 20210001665160-21-002270EDGAR
- Form 1-ANov 25, 20200001104659-20-129394EDGAR
- Form C-UJul 30, 20200001665160-20-001009EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.